All Stories

  1. P.0601 Thyroid hormones levels in patients with schizophrenia receiving conventional and atypical antipsychotics

    Article • European Neuropsychopharmacology, December 2021, Elsevier

    Dr Olga Lobacheva

  2. Effects of long-term therapy with quetiapine and olanzapine on parameters of immunity and cytokine levels in patients with schizophrenia

    Article • European Psychiatry, April 2021, Royal College of Psychiatrists

    Dr Olga Lobacheva, Svetlana Vladimirova

  3. Body Fat Parameters, Glucose and Lipid Profiles, and Thyroid Hormone Levels in Schizophrenia Patients with or without Metabolic Syndrome

    Article • Diagnostics, September 2020, MDPI AG

    Prof. dr. Anton J Loonen, Prof Nikolay A. Bokhan, Svetlana A Ivanova, Dr Olga Lobacheva

  4. Parameters of immunity and level of cortisol in schizophrenic patients under long-term therapy with risperidone

    Article • European Neuropsychopharmacology, January 2019, Elsevier

    Prof Nikolay A. Bokhan, Dr Olga Lobacheva

  5. Prediction of visceral obesity in schizophrenic patients under therapy with antipsychotics

    Article • European Neuropsychopharmacology, January 2019, Elsevier

    Prof Nikolay A. Bokhan, Dr Olga Lobacheva

  6. Olfaction, pain sensitivity and immunoendocrine system in substance use disorders

    Article • American Journal on Addictions, August 2017, Wiley

    Prof Nikolay A. Bokhan, Dr Olga Lobacheva, Valentina Nikitina, Professor Tamara P. Vetlugina

  7. PSYCHOMETRIC EVALUATION OF SYMPTOMS AND CLINICAL DYNAMICS OF SCHIZOPHRENIA IN DEPENDING ON CONSTITUTIONALLY-MORPHOLOGICAL TYPE OF THE PATIENTS

    Article • Bulletin of Siberian Medicine, January 2016, Siberian State Medical University

    Dr Olga Lobacheva, Prof Nikolay A. Bokhan

  8. Interferon gamma inducer in therapy of schizophrenia

    Article • Acta Neuropsychiatrica, November 2015, Cambridge University Press

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva, Valentina Nikitina

  9. Association of Cytokine Production with Hormone Level and Sensory Responses during the Formation of Psychoactive Drug Addiction in Men

    Article • Bulletin of Experimental Biology and Medicine, October 2015, Springer Science + Business Media

    Valentina Nikitina, Dr Olga Lobacheva, Prof Nikolay A. Bokhan

  10. P.1.f.004 Immunomodulating effects of classical and atypical antipsychotics

    Article • European Neuropsychopharmacology, October 2014, Elsevier

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva

  11. 1585 – Social adaptation and immune reactivity in schizophrenia

    Article • European Psychiatry, January 2013, Elsevier

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva

  12. P03-264 - Dynamics of psychopathological symptomatology and cytokine levels in the process of schizophrenic patients treatment

    Article • European Psychiatry, January 2011, Elsevier

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva

  13. P.3.f.012 Psychoneuroimmune interactions in schizophrenia

    Article • European Neuropsychopharmacology, August 2010, Elsevier

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva

  14. P03-84 - Immune reactivity and variants of clinical-social adaptation in schizophrenia

    Article • European Psychiatry, January 2010, Elsevier

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva

  15. TECHNOLOGY OF IMMUNOCORRECTION AT MENTAL DISORDERS

    Article • January 2010, Euroasian Scientific and Industrial Chamber, Ltd.

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva, Valentina Nikitina

  16. P.3.d.01l The immunomodulatory effects of atypical neuroleptics quetiapine and amisulpride in the dynamics of 6-week treatment

    Article • European Neuropsychopharmacology, September 2009, Elsevier

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva

  17. P.3.d.011 Immunotropic effects of atypical neuroleptics olanzapine and amisulpride

    Article • European Neuropsychopharmacology, August 2008, Elsevier

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva, Prof Nikolay A. Bokhan

  18. Immune parameters and aminotransferase blood serum level in dynamics of atypical neuroleptics treatment of schizophrenic patients

    Article • European Psychiatry, April 2008, Elsevier

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva

  19. P.2.021 Effects of atypical neurolepticquetiapine on blood indices, humoral immunity and body weight in patients with schizophrenia

    Article • European Neuropsychopharmacology, January 2005, Elsevier

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva

  20. P.2.016 Influence of atypical neuroleptic on cell apoptosis in patients with schizophrenia in the course of the therapy

    Article • European Neuropsychopharmacology, January 2005, Elsevier

    Dr Olga Lobacheva, Svetlana A Ivanova

  21. Stress and immunity by change of place of residence

    Article • Pathophysiology, June 1998, Elsevier

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva, Valentina Nikitina

  22. The basic variants of immune function in schizophrenia

    Article • Biological Psychiatry, July 1997, Elsevier

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva

  23. Ego defense mechanisms and immunological status

    Article • Biological Psychiatry, July 1997, Elsevier

    Professor Tamara P. Vetlugina, Dr Olga Lobacheva, Valentina Nikitina